These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 94225)

  • 41. Effective local anesthesia for onabotulinumtoxin A injections to treat hyperhidrosis associated with traumatic amputation.
    Shi LL; Sargen MR; Chen SC; Arbiser JL; Pollack BP
    Dermatol Online J; 2016 Jun; 22(6):. PubMed ID: 27617615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of topical liposome incorporated clove oil in the treatment of idiopathic palmar hyperhidrosis: Single-blinded placebo-controlled study.
    Ibrahim IM; Abdel Kareem IM; Alghobashy MA
    J Cosmet Dermatol; 2018 Dec; 17(6):1084-1089. PubMed ID: 29285889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An open-label tolerability and efficacy study of an aluminum sesquichlorohydrate topical foam in axillary and palmar primary hyperhidrosis.
    Innocenzi D; Ruggero A; Francesconi L; Lacarrubba F; Nardone B; Micali G
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S27-30. PubMed ID: 18727813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Axillary hyperhidrosis - topical treatment with aluminium chloride hexahydrate.
    Ellis H; Scurr JH
    Postgrad Med J; 1979 Dec; 55(654):868-9. PubMed ID: 548949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Axillary hyperhidrosis treated with alcoholic solution of aluminium chloride hexahydrate.
    Scholes KT; Crow KD; Ellis JP; Harman RR; Saihan EM
    Br Med J; 1978 Jul; 2(6130):84-5. PubMed ID: 667571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Open-Label Cohort Study to Evaluate Efficacy and Safety of Application of Glycopyrronium Cloth, 2.4% for Palmar Hyperhidrosis.
    Pariser D; Rivera E; Benedict D
    J Drugs Dermatol; 2022 May; 21(5):488-495. PubMed ID: 35533035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies on topical antiperspirant control of axillary hyperhidrosis.
    Shelley WB; Hurley HJ
    Acta Derm Venereol; 1975; 55(4):241-60. PubMed ID: 52254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Axillary hyperhidrosis.
    Bird D
    Br Med J; 1978 Jul; 2(6133):357. PubMed ID: 687921
    [No Abstract]   [Full Text] [Related]  

  • 49. Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use.
    Lamb YN
    Clin Drug Investig; 2019 Nov; 39(11):1141-1147. PubMed ID: 31571127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Supression of sweating in palmar hyperhydrosis with 5% strontium chloride hexahydrate.
    Akyol M; Berksoy Hayta S; Yasak R; Özçelİk S
    Dermatol Ther; 2015; 28(5):267-8. PubMed ID: 25818839
    [No Abstract]   [Full Text] [Related]  

  • 51. Reversible anisocoria due to inadvertent ocular exposure to topical anticholinergic treatment for primary axillary hyperhidrosis.
    Pashaei-Marandi A; Assam JH; Arnold A; Lee AG; Bonelli L
    Can J Ophthalmol; 2019 Dec; 54(6):e300-e302. PubMed ID: 31836120
    [No Abstract]   [Full Text] [Related]  

  • 52. Variables Affecting Delivery of Glycopyrronium Tosylate Through Human Skin In Vitro.
    Caserta F; Lenn J; Hofland H
    J Drugs Dermatol; 2020 Nov; 19(11):1080-1085. PubMed ID: 33196749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Letter: Axillary hyperhidrosis.
    Shelley WB; Hurley HJ
    JAMA; 1975 Sep; 233(12):1257. PubMed ID: 1174180
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical evaluation of an antiperspirant for hyperhidrosis.
    Celleno L; Mastropietro F; Tolaini MV; Pigatto PD
    G Ital Dermatol Venereol; 2019 Jun; 154(3):338-341. PubMed ID: 30249082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topical glycopyrrolate for axillary hyperhidrosis.
    Mackenzie A; Burns C; Kavanagh G
    Br J Dermatol; 2013 Aug; 169(2):483-4. PubMed ID: 23496205
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of bromhidrosis with a glycine-soja sterocomplex topical product.
    Gregoriou S; Rigopoulos D; Chiolou Z; Papafragkaki D; Makris M; Kontochristopoulos G
    J Cosmet Dermatol; 2011 Mar; 10(1):74-7. PubMed ID: 21332920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and efficacy of topical formulations containing 0·5, 1 and 2% glycopyrronium bromide in patients with primary axillary hyperhidrosis: a randomized, double-blind, placebo-controlled study.
    Masur C; Soeberdt M; Kilic A; Knie U; Abels C
    Br J Dermatol; 2020 Jan; 182(1):229-231. PubMed ID: 31218668
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of hyperhidrosis with topical methenamine.
    Bergstresser PR; Quero R
    Int J Dermatol; 1976; 15(6):452-5. PubMed ID: 776880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A medical alternative for the treatment of localized hyperhidrosis].
    Cladellas Gutiérrez E; Callejas Pérez MA; Grimalt Santacana R
    Arch Bronconeumol; 2008 Dec; 44(12):692-3. PubMed ID: 19091240
    [No Abstract]   [Full Text] [Related]  

  • 60. [Topical glycopyrrolate in craniofacial hyperhidrosis].
    Callejas MA; Grimalt R
    Med Clin (Barc); 2008 Jun; 131(4):157. PubMed ID: 18601830
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.